Circ_0010235 confers cisplatin resistance in lung cancer by upregulating <scp>E2F7</scp> through absorbing <scp>miR</scp>‐379‐5p

Abstract

Circ_0010235 knockdown reduced DDP resistance and tumor growth via miR-379-5p/ E2F7 axis in lung cancer, suggesting an effective therapeutic target for lung cancer patients.